サインイン

このコンテンツを視聴するには、JoVE 購読が必要です。 サインイン又は無料トライアルを申し込む。

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Intrafemoral injections allow for the engraftment of a small number of hematopoietic stem and progenitor cells (HSPCs), by placing the cells directly in the bone marrow cavity. Here we describe an experimental protocol of intrafemoral injection of human HSPCs into immunodeficient mice.

Abstract

Hematopoietic stem cells (HSCs) are defined by their lifelong ability to produce all blood cell types. This is operationally tested by transplanting cell populations containing HSCs into syngeneic or immunocompromised mice. The size and multilineage composition of the graft is then measured over time, usually by flow cytometry. Classically, a population containing HSCs is injected into the circulation of the animal, after which the HSCs home to the bone marrow, where they lodge and begin blood production. Alternatively, HSCs and/or progenitor cells (HSPCs) can be placed directly in the bone marrow cavity.

This paper describes a protocol for intrafemoral injection of human HSPCs into immunodeficient mice. In short, preconditioned mice are anesthetized, and a small hole is drilled through the knee into the femur using a needle. Using a smaller insulin needle, cells are then injected directly into the same conduit created by the first needle. This method of transplantation can be applied in varied experimental designs, using either mouse or human cells as donor cells. It has been most widely used for xenotransplantation, because in this context, it is thought to provide improved engraftment over intravenous injections, therefore improving statistical power and reducing the number of mice to be used.

Introduction

Blood has one of the highest regeneration rates in the human body, producing 1 × 1012 cells per day in the adult human bone marrow1. Hematopoietic stem cells (HSCs) guarantee blood production over the lifespan by the process of hematopoiesis and are defined by their capacity to produce all blood cell types (multipotentiality) while maintaining themselves (self-renewal). Historically, the gold standard for testing the function of an HSC has always relied on transplantation, testing the ability of a donor population to reconstitute all blood lineages of a mouse long-term (commonly defined as a minimum of 20 weeks)

Protocol

All animal research presented here adheres to the Animals (Scientific Procedures) Act 1986 Amendment Regulations 2012 and was performed after ethical review and approval by the University of Cambridge Animal Welfare and Ethical Review Body (AWERB). Female NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (NSG) mice, aged between 12 and 16 weeks (~21-30 g), bred in-house and maintained in a Specific-Pathogen-Free animal facility, were used for intrafemoral injections. De-identified CB samples were collected from healt.......

Representative Results

The engraftment of the intrafemorally injected cells can be assessed at any time point from 24 h onwards depending on the experimental design. At the end time point, IF, BM, PB, and spleens may be collected. These can be processed, and the level of engraftment assessed via flow cytometry. To robustly call human engraftment even at low levels, we stained with two distinct antibodies against human CD45 (clone HI30 and clone 2D1). Only cells positive for both antibodies (CD45++) were considered of human origin. T.......

Discussion

Intrafemoral injections are a useful tool in xenotransplantation when only a small number of HSPCs are available, providing improved engraftment compared to intravenous injections. However, the technique requires dexterity and training. When practicing, we would recommend using fresh cadavers of the correct weight range (see below) and injecting a colored dye (such as trypan blue) so that upon dissection, it is clear if the injection went into the femur and was restricted to it (no dye should be observed in the muscles)........

Acknowledgements

The authors acknowledge the group of Dr John Dick for previous work on this method, and Monica Doedens for training. We are grateful to the Cambridge Blood and Stem Cell Biobank (CBSB), specifically Dr. Joanna Baxter and the team of CBSB nurses who consented and collected cord blood samples; our sample donors; the University Biomedical Service, specifically Nicolas Lumley and staff at The Anne McLaren Building for maintenance of our mice strains and support of our in vivo experiments; Shaaezmeen Basheer for editing of the manuscript.

E.L. is funded by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal So....

Materials

NameCompanyCatalog NumberComments
0.5 mL Insulin Syringe with 29 G x 12.7 mm NeedleBD324892
1 mL Insulin Syringe with 29 G x 0.5" NeedleBD324827
1.5 mL tubeFisherbrand509-GRD-PFB
3 mL syringe HENKE SASS WOLF GMBH4020.000V0
5 mL Round Bottom Polystyrene Test Tube with Cell Strainer Cap 12 x 75 mmFalcon352235FACS tube
5 mL Round Bottom Polystyrene Test Tube with Snap Cap 12 x 75 mmFalcon352058FACS tube
27 G 1/2" needle BD 300635
40 µm cell strainer for 50 mL tubeGreiner Bio-one542040
50 mL tubeSarstedt Ltd62.547.254
96 well round-bottom plate Falcon351177
Alcohol SwabVITREX MEDICAL A/S520213
BD LSR Fortessa X-20 Cell Analyzer BDflow cytometer
BuphrenorphineAnimalcareXVD190
CD14/PECy7 (Clone M5E2)biolegend301814Used at 1 in 1000
CD19/Alexa 700 (Clone HIB19)biolegend302226Used at 1 in 300
CD19/FITC (Clone HIB19)biolegend302206Used at 1 in 200
CD3/APCCy7 (Clone HIT3a)biolegend300318Used at 1 in 100
CD33/APC (Clone P67.6)BD345800Used at 1 in 200
CD45/BV510 (Clone HI30)biolegend304036Used at 1 in 500
CD45/PECy5 (Clone 2D1)biolegend368526Used at 1 in 300
CompBeads Anti-Mouse Ig, κ/Negative Control Compensation Particles SetBD552843
Dnase 1Worthington BiochemicalLS002139
Fetal Bovine Serum (FBS)PAN-BiotechP40-37500
Glycophorin A (GlyA)/PE (Clone GA-R2)BD340947Used at 1 in 1000
Iscove Modified Dulbecco Media (IMDM)PAN-BiotechP04-20250
Isoflurane (IsoFlo 100% w/w Inhalation Vapor, liquid)Zoetis115095
Microvette 300 Lithium heparin LH, 300 µLSarstedt Ltd20.1309Mouse blood collection tube
NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (NSG) mice Charles River 
Pancoll human, Density: 1.077 g/mLPAN-BiotechP04-60500
Penicillin-Streptomycin Gibco15140122
Phosphate Buffered Saline (PBS)Gibco14190169

References

  1. Dancey, J. T., Deubelbeiss, K. A., Harker, L. A., Finch, C. A. Neutrophil kinetics in man. J Clin Invest. 58 (3), 705-715 (1976).
  2. Purton, L. E., Scadden, D. T. Limiting factors in murine hematopoietic stem cell assays. Cell Stem Cell....

Explore More Articles

Keywords Hematopoietic Stem CellsHSCsHematopoietic Stem And Progenitor CellsHSPCsXenotransplantationIntrafemoral InjectionImmunocompromised MiceBone MarrowGraftFlow CytometryBlood Cell Types

This article has been published

Video Coming Soon

JoVE Logo

個人情報保護方針

利用規約

一般データ保護規則

研究

教育

JoVEについて

Copyright © 2023 MyJoVE Corporation. All rights reserved